Dr Cheng Hwee Soh is a Research Officer who is driven by a desire to expand human healthspan as lifespans have increased over the past decades. With a background in geriatric rehabilitation, Dr Soh works to predict and improve clinical outcomes for patients at risk, leading to significant advancements that are translated into clinical practice. Graduating with a Bachelor of Biomedicine (Hons) and a Doctor of Philosophy, Dr Soh's expertise plays a crucial role in enhancing the recovery process of older patients in rehabilitation clinics.

As a Research Officer at the Baker Institute's Imaging Research lab, Dr Soh's current research focus is centered around predicting Stage B Heart Failure and coronary artery disease, particularly regarding cancer survivors. This is due to the differences in the treatment history between cancer survivors and the non-cancer population.

Dr Soh is involved in various key projects that strive to make a difference in the cardiology and cardio-oncology fields. These include:

1. The AGILE-Echo study, an RCT aims to investigate the utilization of artificial intelligence guided transthoracic echocardiograms in remote areas around Australia.
2. The REDEEM-CAD study, a cohort study examining the risk of coronary artery disease among cancer survivors.
3. The REDEEM study, an RCT with an objective to analyze the feasibility and value of risk-guided cardiac rehabilitation as a component of survivorship care for cancer survivors diagnosed with Stage B Heart Failure.
4. The UK-Biobank in collaboration with the University of Cambridge, aimed at generating new risk scores to predict the incidence of heart failure among cancer survivors.

Dr Cheng Hwee Soh is dedicated to making a lasting impact by identifying key patient characteristics tied to poor cardiac function and developing strategies to help identifying those who are of higher risk.